The Portland Trail Blazers got hit with a tough setback Monday, with Shaedon Sharpe expected to miss at least six months after suffering a meniscus injury, according to Shams Charania. No immediate date was given for when the injury happened, but the timeline would keep Sharpe out well into the 2026-27 season.
It’s a harsh turn for a player the Blazers were counting on to keep climbing after a breakthrough year. Portland had just made the playoffs last season, ending a four-year drought, and Sharpe was supposed to be part of the next push.
The former lottery pick put together the best season of his career before the injury news. He played in 50 games and made 42 starts, logging a little over 29 minutes a night. Sharpe averaged 20.8 points, 4.3 rebounds, 2.6 assists and 1.4 steals while shooting 45.2 percent from the field, 33.7 percent from 3-point range and 78.7 percent from the free-throw line.
He also appeared in all five games of Portland’s opening-round playoff loss to the San Antonio Spurs. In that series, he averaged 7.2 points and 1.6 rebounds in a little over 13 minutes per game, shooting 41.2 percent from the field, 27.3 percent from deep and 62.5 percent at the line.
Sharpe’s run of injury setbacks has stretched beyond this latest issue. As a rookie, he played in 80 games.
In his second season, an abdominal injury in February of 2024 ended his year early. Last season brought the leg injury, though he did manage to come back in time for the playoffs.
In Other News...
Shaedon Sharpe Injury Just Put His Blazers Future In Doubt
Shaedon Sharpes latest setback comes at a tough time for a Trail Blazers backcourt that already looks different from the one he was trying to carve out a bigger role in. Portlands plan has been reshaped around a new group of guards, with names like Ja Morant and Damian Lillard now part of the conversation, and Sharpe had already been working to fit into a more crowded structure under head coach Micah Nori after posting a fairly high usage rate in his previous role.
Now the torn meniscus changes the timeline as much as the depth chart. Sharpe is expected to miss about six months, which puts his return well after the All-Star break and could push his recovery right into the stretch where Portland has to make larger decisions about the roster and its future. For a player whose place in the rotation was already less certain than it once seemed, the injury has only made the next chapter in Portland harder to read. [Read more 🡒]
Hawks Face One Big Question In Proposed Blazers Wing Swap
Shaedon Sharpes injury has quickly shifted the conversation in Portland from upside to uncertainty, with the young wing now expected to miss six months because of a torn meniscus. For a Trail Blazers team trying to balance long-term talent with present-day roster planning, that kind of setback naturally invites questions about whether holding onto a promising but unavailable piece remains the best path forward.
One possible route gaining attention is a swap with Atlanta involving Jonathan Kuminga, a player looking for a new contract and one whose next deal could fit into the kind of broader roster and cap maneuvering both teams are exploring. The framework makes sense on paper for each side, but for now it remains only a proposal, with no official deal announced and plenty still unresolved about whether the sides will actually meet in the middle. [Read more 🡒]
Shaedon Sharpe's Price Just Got Harder For Blazers Fans To Ignore
Bennedict Mathurins latest deal offers a useful measuring stick for where the market is heading around young wing scorers, and Portland fans cant help but look at it through the lens of Shaedon Sharpe. Mathurin was the No. 6 pick in the 2022 draft, has cleared 17 points per game over each of the past two seasons, and now has a contract that reflects the value teams place on that kind of upside. For a Blazers team still sorting out its future core, it is another reminder that the price tag on promising perimeter talent is only going one direction.
Sharpes situation makes the comparison even tougher to ignore. Portland has invested in his talent and seen enough flashes to know why he matters, but his recent injury adds a new layer of uncertainty to any conversation about what comes next. With Mathurins value now out in the open and Sharpe still carrying questions about health and availability, the Blazers are left weighing not just what he can become, but how much patience and financial commitment that future will require. [Read more 🡒]